- Home
- MI vs LSTA Comparison
MI vs LSTA Comparison
Compare MI & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MI
- LSTA
- Stock Information
- Founded
- MI 2009
- LSTA 1980
- Country
- MI Hong Kong
- LSTA United States
- Employees
- MI N/A
- LSTA N/A
- Industry
- MI Catalog/Specialty Distribution
- LSTA Misc Health and Biotechnology Services
- Sector
- MI Consumer Discretionary
- LSTA Health Care
- Exchange
- MI Nasdaq
- LSTA Nasdaq
- Market Cap
- MI 17.8M
- LSTA 20.9M
- IPO Year
- MI N/A
- LSTA N/A
- Fundamental
- Price
- MI N/A
- LSTA $2.53
- Analyst Decision
- MI
- LSTA Strong Buy
- Analyst Count
- MI 0
- LSTA 2
- Target Price
- MI N/A
- LSTA $23.50
- AVG Volume (30 Days)
- MI 15.5K
- LSTA 32.8K
- Earning Date
- MI 01-01-0001
- LSTA 11-11-2025
- Dividend Yield
- MI N/A
- LSTA N/A
- EPS Growth
- MI N/A
- LSTA N/A
- EPS
- MI N/A
- LSTA N/A
- Revenue
- MI $662,718.00
- LSTA $1,070,000.00
- Revenue This Year
- MI N/A
- LSTA N/A
- Revenue Next Year
- MI N/A
- LSTA N/A
- P/E Ratio
- MI N/A
- LSTA N/A
- Revenue Growth
- MI N/A
- LSTA N/A
- 52 Week Low
- MI $1.57
- LSTA $1.87
- 52 Week High
- MI $10.29
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- MI N/A
- LSTA 54.11
- Support Level
- MI N/A
- LSTA $2.36
- Resistance Level
- MI N/A
- LSTA $2.62
- Average True Range (ATR)
- MI 0.00
- LSTA 0.19
- MACD
- MI 0.00
- LSTA 0.02
- Stochastic Oscillator
- MI 0.00
- LSTA 71.70
About MI NFT Limited
NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.